2-Morpholino-5-(1H-pyrrol-1-yl)benzoic acid, 97.0%, 1g

7-FLUORO-6-METHOXYISOINDOLIN-1-ONE, 95.0%, 5g

2,5-Bis(4-diethylaminophenyl)-1,3,4-oxadiazole>98.0%(T)(HPLC)25g

Bicyclo[1.1.1]pentane-1,3-diyldimethanol, 98%, 500mg

(S)-2-(4-Benzylpiperazin-2-yl)acetonitrile, 98%, 100mg

Phenylacetic Hydrazide>98.0%(GC)(T)25g

4-Aminohippuric Acid>99.0%(T)10g

(1'R,2'R,3aS,3"aS,8aR,8"aR)-(+)-3,3",3a,3"a,8,8",8a,8"a-Octahydrodispiro{2H-indeno[1,2-d]oxazole-2,1'-cyclohexane-2',2"-[2H]indeno[1,2-d]oxazole}, 97%, 1g

Ethyl 5-bromothiazole-4-carboxylate, 95.0%, 100g

(R)-N-((R)-Adamantan-1-yl(5-(diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide, 98%, 250mg

O-(4-(Trifluoromethyl)phenyl)hydroxylamine, 97.0%, 250mg

(R)-4-BROMO-2-[[(TERT-BUTOXY)CARBONYL]AMINO]BUTANOIC ACID TERT-BUTYL ESTER, 95.0%, 1g

2-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethan-1-ol, 95+%, 5g